Vanda Pharmaceuticals
VNDA
#7861
Rank
NZ$0.55 B
Marketcap
NZ$9.33
Share price
3.65%
Change (1 day)
13.39%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Cash on Hand

Cash on Hand as of September 2025 : NZ$0.50 Billion

According to Vanda Pharmaceuticals's latest financial reports the company has NZ$0.50 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Vanda Pharmaceuticals - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.66 B8.2%
2023-12-31NZ$0.61 B-16.51%
2022-12-31NZ$0.73 B16.05%
2021-12-31NZ$0.63 B24.33%
2020-12-31NZ$0.50 B9.97%
2019-12-31NZ$0.46 B20.79%
2018-12-31NZ$0.38 B90%
2017-12-31NZ$0.20 B-1.04%
2016-12-31NZ$0.20 B-2.46%
2015-12-31NZ$0.20 B26.26%
2014-12-31NZ$0.16 B4.46%
2013-12-31NZ$0.15 B8.38%
2012-12-31NZ$0.14 B-23.28%
2011-12-31NZ$0.19 B-25.68%
2010-12-31NZ$0.25 B-9.18%
2009-12-31NZ$0.28 B253.06%
2008-12-31NZ$80.05 M-28%
2007-12-31NZ$0.11 B145.79%
2006-12-31NZ$45.23 M-0.75%
2005-12-31NZ$45.58 M100.03%
2004-12-31NZ$22.78 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
NZ$16.88 B 3,220.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$17.16 B 3,274.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$32.13 B 6,218.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$28.56 B 5,517.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$25.93 B 5,000.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
NZ$4.85 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$31.52 B 6,100.47%๐Ÿ‡บ๐Ÿ‡ธ USA